Maria Sharapova to appeal ITF doping ban: ‘I cannot accept an unfairly harsh two-year suspension’
LONDON // Maria Sharapova said on Wednesday she will appeal the two-year ban handed down to her by the International Tennis Federation (ITF) for doping and which threatens to end her career.
The 29-year-old Russian tested positive for the controversial banned medication meldonium during January’s Australian Open.
“While the tribunal concluded correctly that I did not intentionally violate the anti-doping rules, I cannot accept an unfairly harsh two-year suspension,” Sharapova wrote on her Facebook page.
“The tribunal, whose members were selected by the ITF, agreed that I did not do anything intentionally wrong, yet they seek to keep me from playing tennis for two years. I will immediately appeal the suspension portion of this ruling to CAS, the Court of Arbitration for Sport.”
Sharapova said then she was not aware that the World Anti-Doping Agency (Wada) had barred athletes from using meldonium, also known as mildronate, as of January 1.
Her lawyer, John Haggerty, said Sharapova took the substance after that date.
Wednesday’s ruling said Sharapova did not intend to cheat, but bore “sole responsibility” and “very significant fault” for the positive test.
In addition to testing positive at the Australian Open, she also failed a test for meldonium in an out-of-competition control in Moscow on February 2, the ITF said.
The two-year ban can be appealed to the Court of Arbitration for Sport.
Sharapova said she first was prescribed the Latvian-made drug, typically used for heart conditions, for medical reasons in 2006. She could have been barred from competing for up to four years.
The ITF ruling in Sharapova’s case follows a hearing before a three-person panel. Lawyers representing the ITF argued their side, while Haggerty argued hers. He said she spoke at the hearing.
The ban throws into doubt the on-court future of Sharapova, who is one of the most well-known – and, thanks to a wide array of endorsements – highest-earning athletes in the world.
She is a former top-ranked player who is one of 10 women in tennis history with a career Grand Slam – at least one title from each of the sport’s four most important tournaments. So much came so easily for her at the start: Wimbledon champion in 2004 at age 17; No 1 in the rankings at 18; US Open champion at 19; Australian Open champion at 20.
An operation to her right shoulder in 2008 took her off the tour for months, and her ranking dropped outside the top 100. But she worked her way back, and in 2012, won the French Open, then added a second title in Paris two years later.
Sharapova hasn’t played since a quarter-final loss to Serena Williams at this year’s Australian Open, and she is ranked 26th this week.
Meldonium increases blood flow, which improves exercise capacity by carrying more oxygen to the muscles.
In April, citing a lack of scientific evidence about how long the drug remains in a person’s system, Wada said that provisional suspensions may be lifted if it is determined that an athlete took meldonium before it went on the list of banned substances.
About 200 athletes tested positive for meldonium this year from various sports and countries – many, like Sharapova, were Russian – and some said the drug stayed in their systems for months even though they stopped using it in 2015.
But, according to Haggerty, that was not the case for Sharapova.
Her ban is backdated to January 26 and due to end on January 25, 2018.
She has had her results from the Australian Open annulled and has forfeited her tournament prize money and ranking points.
Follow us on Twitter @NatSportUAE
Like us on Facebook at facebook.com/TheNationalSport
Updated: June 8, 2016 04:00 AM